p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases.
作者： Sanjay Kumar , Jeffrey Boehm , John C. Lee
DOI: 10.1038/NRD1177
关键词: Neuroscience 、 Serine 、 Mitogen-activated protein kinase 、 Kinase 、 Biology 、 Inflammation 、 p38 mitogen-activated protein kinases 、 Cell biology 、 ASK1 、 Disease 、 Signalling molecules
摘要: The p38 MAP kinases are a family of serine/threonine protein kinases that play important roles in cellular responses to external stress signals. Since their identification about 10 years …
nature.com
sci-hub.se 参考文章(73)
Georg H. Waetzig, Dirk Seegert, Philip Rosenstiel, Susanna Nikolaus, Stefan Schreiber, p38 Mitogen-Activated Protein Kinase Is Activated and Linked to TNF-α Signaling in Inflammatory Bowel Disease Journal of Immunology. ,vol. 168, pp. 5342- 5351 ,(2002) , 10.4049/JIMMUNOL.168.10.5342
Takuji Tanoue, Takuya Yamamoto, Ryota Maeda, Eisuke Nishida, A Novel MAPK Phosphatase MKP-7 Acts Preferentially on JNK/SAPK and p38α and β MAPKs Journal of Biological Chemistry. ,vol. 276, pp. 26629- 26639 ,(2001) , 10.1074/JBC.M101981200
Jerry L. Adams, Alison M. Badger, Sanjay Kumar, John C. Lee, p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Progress in Medicinal Chemistry. ,vol. 38, pp. 1- 60 ,(2001) , 10.1016/S0079-6468(08)70091-2
B. Ge, MAPKK-Independent Activation of p38alpha Mediated by TAB1-Dependent Autophosphorylation of p38alpha Science. ,vol. 295, pp. 1291- 1294 ,(2002) , 10.1126/SCIENCE.1067289
E. H. Ohlstein, S. Kassis, B. R. Smith, J. C. Lee, A. H. Nelson, F. C. Barone, J. J. Legos, E. A. Irving, A. M. Ray, S. Kumar, J. L. Adams, A. M. Badger, R. F. White, A. A. Parsons, A. J. Hunter, K. Ward, M. J. McVey, J. A. Erhardt, SB 239063, a Second-Generation p38 Mitogen-Activated Protein Kinase Inhibitor, Reduces Brain Injury and Neurological Deficits in Cerebral Focal Ischemia Journal of Pharmacology and Experimental Therapeutics. ,vol. 296, pp. 312- 321 ,(2001)
D E Griswold, B Votta, J C Lee, J L Adams, A M Badger, J N Bradbeer, Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. Journal of Pharmacology and Experimental Therapeutics. ,vol. 279, pp. 1453- 1461 ,(1996)
J. Lee Pellegrino-Gensey, Elizabeth A. Malloy, Bohumila Fahmy, Gilbert C. Olini, Wei Wu, Peter H. Schafer, Michael P. Wachter, Janet E. Davis, Scott A. Wadsworth, Druie E. Cavender, John J. Siekierka, Scott A. Beers, Praful Lalan, RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Journal of Pharmacology and Experimental Therapeutics. ,vol. 291, pp. 680- 687 ,(1999)
Keith P. Wilson, Patricia G. McCaffrey, Kathy Hsiao, Sam Pazhanisamy, Vincent Galullo, Guy W. Bemis, Matthew J. Fitzgibbon, Paul R. Caron, Mark A. Murcko, Michael S.S. Su, The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase Chemistry & Biology. ,vol. 4, pp. 423- 431 ,(1997) , 10.1016/S1074-5521(97)90194-0
D. Caput, B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, A. Cerami, Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators Proceedings of the National Academy of Sciences of the United States of America. ,vol. 83, pp. 1670- 1674 ,(1986) , 10.1073/PNAS.83.6.1670
Zhonghong Guan, ShaAvhree Y. Buckman, Alice P. Pentland, Dennis J. Templeton, Aubrey R. Morrison, Induction of Cyclooxygenase-2 by the Activated MEKK1 → SEK1/MKK4 → p38 Mitogen-activated Protein Kinase Pathway Journal of Biological Chemistry. ,vol. 273, pp. 12901- 12908 ,(1998) , 10.1074/JBC.273.21.12901